Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Irinotecan FOLFIRI + Bevacizumab in Advanced Colorectal Cancer
NCT05969899Phase 2Active, not recruiting
- Sponsor
- Fudan University
- Start
- Jul 2023
- Primary completion
- Jul 2025
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan liposome injection in colorectal cancer (CRC), sponsored by Fudan University. Started Jul 2023; status: active, not recruiting.
02
Drugs
irinotecan liposome injection
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05969899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05969899.